Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $21.72 USD
Change Today -0.03 / -0.14%
Volume 339.7K
MNTA On Other Exchanges
Symbol
Exchange
Frankfurt
As of 2:15 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - momenta pharmaceuticals inc (MNTA)

Name (Connections)Board RelationshipsTitleKey Developments
James Sulat MBA 52 RelationshipsChairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee 
John Clarke 90 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Audit Committee 
Bruce Downey J.D. 56 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee 

Compensation Committee* - momenta pharmaceuticals inc (MNTA)

Name (Connections)Board RelationshipsTitle
John Clarke 90 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Audit Committee
Bruce Downey J.D. 56 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
Thomas Koestler Ph.D. 59 RelationshipsDirector, Member of Compensation Committee and Member of Science Committee
Bennett Shapiro M.D. 117 RelationshipsIndependent Director, Chairman of Science Committee and Member of Compensation Committee
MNTA Compensation vs. Industry
643.4K
360.3K
Chief Executive Officer
374.8K
263.9K
Chief Financial Officer
Share price activity for MOMENTA PHARMACEUTICALS INC (MNTA)
52 Week Price Performance
MNTA
Industry Average

Nominating Committee* - momenta pharmaceuticals inc (MNTA)

Name (Connections)Board RelationshipsTitleKey Developments
James Sulat MBA 52 RelationshipsChairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit CommitteeMomenta Pharmaceuticals Announces Executive Changes
06/25/15
Elizabeth Stoner M.D., M.S. 33 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Science CommitteePeter Barton Hutt to Retire from Momenta Pharmaceuticals Inc.'s Board of Directors, Effective December 31, 2014
12/15/14

Corporate Governance Committee* - momenta pharmaceuticals inc (MNTA)

Name (Connections)Board RelationshipsTitle
Elizabeth Stoner M.D., M.S. 33 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Audit Committee
James Sulat MBA 52 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
MNTA and Competitor
Insiders vs. External
Board
5%
95%
Momenta Pharmaceuticals Inc.
17%
83%
SciClone Pharmaceuticals, Inc.
15%
85%
Amarin Corporation plc
25%
75%
OraSure Technologies, Inc.
19%
81%
Amphastar Pharmaceuticals, Inc.
25%
75%
Sucampo Pharmaceuticals, Inc.
Insiders
External Board Members

Advisory Committee* - momenta pharmaceuticals inc (MNTA)

Name (Board Relationships)/Title Board Affiliations
Elliott Antman 19 Relationships
Member of Scientific Advisory Board
No other board affiliations
K. Austen 59 Relationships
Member of Scientific Advisory Board
No other board affiliations
Carolyn Bertozzi 40 Relationships
Member of Scientific Advisory Board
No other board affiliations
Eugene Braunwald 41 Relationships
Member of Scientific Advisory Board
No other board affiliations
Francis Bullock 63 Relationships
Member of Scientific Advisory Board
No other board affiliations
Benito Casu 37 Relationships
Member of Scientific Advisory Board
No other board affiliations
Richard Cooper 19 Relationships
Member of Regulatory Advisory Board
No other board affiliations
J. Crout 21 Relationships
Member of Regulatory Advisory Board
No other board affiliations
Thomas Garvey 19 Relationships
Member of Regulatory Advisory Board
No other board affiliations
Robert Pollock 32 Relationships
Member of Regulatory Advisory Board
No other board affiliations
William Reardon 53 Relationships
Advisor to Audit Committee
No other board affiliations
Phillips Robbins 19 Relationships
Member of Scientific Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MNTA:US $21.72 USD -0.03

MNTA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amarin Corp PLC $2.26 USD +0.0601
Amphastar Pharmaceuticals Inc $16.18 USD +0.43
OraSure Technologies Inc $4.98 USD -0.0765
SciClone Pharmaceuticals Inc $9.11 USD -0.10
Sucampo Pharmaceuticals Inc $21.90 USD +1.00
View Industry Companies
 

Industry Analysis

MNTA

Industry Average

Valuation MNTA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 23.7x
Price/Book 5.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 24.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MOMENTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.